Region Örebro County Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02831608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ole Frobert, MD, PhD | Stockholm | Västerås

Active Ingredients

Drugs in Phase 4 Trials (2)

inactivated influenza vaccine (1 trial)

metoprolol (lopressor) (1 trial)

Drugs in Phase 2 Trials (1)

onabotulinumtoxinA (Botox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Influenza, Human (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Myalgia (Phase 2)

Myocardial Infarction (Phase 4)

Myofascial Pain Syndromes (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3